Assessment of the Argentine ant invasion management by means of manual removal of winter nests in mixed cork oak and pine forestsDIAZ, Mireia; ABRIL, Sílvia; ENRIQUEZ, Martha L et al.Biological invasions. 2014, Vol 16, Num 2, pp 315-327, issn 1387-3547, 13 p.Article

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern AfricaCAMPOS, Nicole G; KIM, Jane J; CASTLE, Philip E et al.International journal of cancer (Print). 2012, Vol 130, Num 11, pp 2672-2684, issn 0020-7136, 13 p.Article

Using HPV prevalence to predict cervical cancer incidenceSHARMA, Monisha; BRUNI, Laia; DIAZ, Mireia et al.International journal of cancer (Print). 2013, Vol 132, Num 8, pp 1895-1900, issn 0020-7136, 6 p.Article

Mathematical Models of Cervical Cancer Prevention in the Asia Pacific RegionGOLDIE, Sue J; DIAZ, Mireia; KIM, Sun-Young et al.Vaccine. Supplement. 2008, Vol 26, Num 12, issn 1359-5938, M17-M29Article

Against which human papillomavirus types shall we vaccinate and screen? The international perspectiveMUNOZ, Nubia; BOSCH, F. Xavier; CASTELISAGUE, Xavier et al.International journal of cancer. 2004, Vol 111, Num 2, pp 278-285, issn 0020-7136, 8 p.Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, I1-I31, SUP8Article

Burden of Human Papillomavirus Infection and Related Diseases in IsraelSHAVIT, Oren; ROURA, Esther; BARCHANA, Micha et al.Vaccine. 2013, Vol 31, issn 0264-410X, I32-I41, SUP8Article

Model-Based Impact and Cost-Effectiveness of Cervical Cancer Prevention in the Extended Middle East and North Africa (EMENA)KIM, Jane J; SHARMA, Monisha; O'SHEA, Meredith et al.Vaccine. 2013, Vol 31, issn 0264-410X, G65-G77, SUP6Article

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological FindingsBRUNI, Laia; DIAZ, Mireia; CASTELLSAGUE, Xavier et al.The Journal of infectious diseases. 2010, Vol 202, Num 12, pp 1789-1799, issn 0022-1899, 11 p.Article

Screening for Cervical Cancer and Human Papillomavirus Vaccination in Israel: RecommendationsBORNSTEIN, Jacob; FISHER, William A; GINSBERG, Gary M et al.Vaccine. 2013, Vol 31, issn 0264-410X, I58-I60, SUP8Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, F1-F31, SUP5Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesXAVIER BOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, G1-G31, SUP6Article

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesGOLDIE, Sue J; O'SHEA, Meredith; GASTINEAU CAMPOS, Nicole et al.Vaccine. 2008, Vol 26, Num 32, pp 4080-4093, issn 0264-410X, 14 p.Article

Risk factors of invasive cervical cancer in MaliBAYO, Siné; BOSCH, F. Xavier; DE SANJOSE, Silvia et al.International journal of epidemiology. 2002, Vol 31, Num 1, pp 202-209, issn 0300-5771Article

Cost-Effectiveness of Cervical Cancer Prevention in Central and Eastern Europe and Central AsiaBERKHOF, Johannes; BOGAARDS, Johannes A; DEMIREL, Erhan et al.Vaccine. 2013, Vol 31, issn 0264-410X, H71-H79, SUP7Article

Mathematical Models of Cervical Cancer Prevention in Latin America and the CaribbeanGOLDIE, Sue J; DIAZ, Mireia; CONSTENLA, Dagna et al.Vaccine. Supplement. 2008, Vol 26, Num 11, issn 1359-5938, L59-L72Article

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology : a meta-analysisDE SANJOSE, Silvia; DIAZ, Mireia; CASTELLSAGUE, Xavier et al.Lancet. Infectious diseases (print). 2007, Vol 7, Num 7, pp 453-459, issn 1473-3099, 7 p.Article

Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult menCASTELLSAGUEE, Xavier; PEELING, Rosanna W; FRANCESCHI, Silvia et al.American journal of epidemiology. 2005, Vol 162, Num 9, pp 907-916, issn 0002-9262, 10 p.Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, H1-H31, SUP7Article

Model-Based Impact and Cost-Effectiveness of Cervical Cancer Prevention in Sub-Saharan AfricaKIM, Jane J; CAMPOSA, Nicole G; O'SHEA, Meredith et al.Vaccine. 2013, Vol 31, issn 0264-410X, F60-F72, SUP5Article

Cost-effectiveness of human papillomavirus vaccination and screening in SpainDIAZ, Mireia; DE SANJOSE, Silvia; ORTENDAHL, Jesse et al.European journal of cancer (1990). 2010, Vol 46, Num 16, pp 2973-2985, issn 0959-8049, 13 p.Article

Exploring the cost-effectiveness of HPV vaccination in Vietnam : Insights for evidence-based cervical cancer prevention policyKIM, Jane J; KOBUS, Katie E; DIAZ, Mireia et al.Vaccine. 2008, Vol 26, Num 32, pp 4015-4024, issn 0264-410X, 10 p.Article

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors : Implications for screening and preventionCASTELLSAGUE, Xavier; DIAZ, Mireia; MEIJER, Chris J. L. M et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 5, pp 303-315, issn 0027-8874, 13 p.Article

HPV type-distribution in women with and without cervical neoplastic diseasesCLIFFORD, Gary; FRANCESCHI, Silvia; DIAZ, Mireia et al.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.26-S3.34Article

Cervical human papillomavirus infection in the female population in Barcelona, SpainDE SANJOSE, Silvia; ALMIRALL, Rosa; BOSCH, F. Xavier et al.Sexually transmitted diseases. 2003, Vol 30, Num 10, pp 788-793, issn 0148-5717, 6 p.Article